Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all persons or entities that: (1)...
-
Covina, Feb. 12, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Biopharmaceutical and Biomedicine Market size was valued at about USD 570.0 Billion in 2024 and expected to...
-
LANGHORNE, Pa., Oct. 30, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare...
-
Covina, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dry Eye Disease has become a common condition which occurs when eye tears aren’t able to provide an adequate lubrication for eyes and occurs if an eye do...
-
Hyderabad, Aug. 02, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “Allergy Treatment Market Report (2023-2028),” the market is estimated at USD 19.47 billion in 2023. It...
-
Hyderabad, Aug. 02, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Atopic Dermatitis Market Report (2023-2028)," the market is estimated at USD 9.39 billion in 2023. It...
-
Hyderabad, July 27, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “ Biopharmaceuticals Market Report (2023-2028),” the market is estimated at USD 478.20 billion in 2023....
-
Hyderabad, July 26, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Dry Eye Disease Market Report (2023-2028)," the market is estimated at USD 5.86 billion in 2023. It is...
-
Hyderabad, March 30, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “Breast Implant Market - (2023 – 2028)," the market is expected to register a CAGR of 7.62%. The...
-
LOS ANGELES, June 06, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...